Loading...
XIDX
KAEF
Market cap180mUSD
Nov 12, Last price  
585.00IDR
Name

Kimia Farma Tbk PT

Chart & Performance

D1W1MN
XIDX:KAEF chart
P/E
—
P/S
0.35
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.05%
Rev. gr., 5y
-1.62%
Revenues
9.22t
-7.20%
2,704,728,409,7032,854,057,690,4793,183,829,303,9093,481,166,441,2593,734,241,101,3094,348,073,988,3854,521,024,379,7594,860,371,483,5245,811,502,656,4316,127,479,369,4037,454,114,741,1889,400,535,476,00010,006,173,023,00012,857,626,593,0009,232,675,971,0009,965,033,049,0009,938,958,364,0009,223,328,056,000
Net income
-334.96b
L-60.23%
55,393,774,86962,506,876,510138,716,044,100171,765,487,458205,133,316,635214,549,154,260234,625,679,206248,849,016,194267,414,092,891326,786,249,091415,895,778,068-12,724,002,00017,638,834,000302,273,634,000-190,472,839,000-1,485,563,806,000-842,272,199,000-334,959,336,000
CFO
236.75b
+54.12%
-28,694,971,000122,014,000,000141,374,547,20083,908,969,798230,612,654,491253,783,664,733286,309,255,381202,843,123,322213,428,524,82732,637,596,011195,745,470,000-1,853,834,642,0001,018,975,185,000-223,924,978,000403,338,511,000-364,575,420,000153,616,294,000236,748,274,000
Dividend
May 23, 202216.32735 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PT Kimia Farma (Persero) Tbk, an Indonesian entity, is engaged in the manufacturing and sale of a diverse range of products, including pharmaceuticals, herbal remedies, iodine, salts, quinine and its derivatives, and vegetable oils. Its business operations are structured across several key divisions: Manufacturing, Distribution, Retail, and Other Services. Beyond these, the company's portfolio extends to the production and sale of generic, ethical, licensed, and narcotic pharmaceuticals, along with over-the-counter drugs, medical equipment, raw materials, and cosmetics. Its extensive distribution network ensures products reach various outlets, including pharmacies, hospital pharmacies, medical centers, and drugstores. Established in 1817, the company maintains its headquarters in Jakarta, Indonesia.
URL
http://www.kimiafarma.co.id
IPO date
Jul 04, 2001
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT